• We have updated the guidelines regarding posting political content: please see the stickied thread on Website Issues.

Deadly Donors: Diseases Spread Via Tissue / Organ Transplant

Min Bannister

Possessed dog
Joined
Sep 5, 2003
Messages
5,998
Death by Hamster

And they look so cute..

Pretty tragic story here from the BBC :(

Three transplant patients in the US are believed to have died from a virus that originated in a pet hamster.

A Rhode Island woman is thought to have caught the lymphocytic choriomeningitis virus (LCMV) from her hamster shortly before her unrelated death last month.

Her organs were given to four people needing transplants. Three have since died as a result of the infection.

The Centers for Disease Control and Prevention is investigating, but experts stressed LCMV is very rare.

David Gifford, director for Rhode Island's state health department, said that, although donated organs were not routinely screened for rodent viruses, patients on the waiting list for organs should not be concerned.

"This is an extremely rare and unusual event," he said.

LCMV infections have been reported in Europe, Australia and Japan.

But the CDC said it was only the second time it had heard of transmission of LCMV through organ transplants.

Two people who received the woman's corneas have yet to be traced.

The officials are carrying out further tests on the woman's hamster, which was found to be carrying LCMV.

The virus typically causes only flu-like symptoms in humans and is transmitted by contact with the rodent's saliva, urine or faeces.

However, transplant patients are vulnerable to more severe complications because their immune defence system is suppressed by the strong drugs they have to take to prevent their body rejecting the donor organ.

Bob Corfield, a spokesman for UK Transplant, said there had been no recorded cases in the UK.

Although Britain does not test for LCMV, he said the risk of infection was extremely low and that the current screening of donors for viruses was highly effective.

"The organ donor's detailed health history is established. A person's recent travel history is also checked.

"Blood tests are carried out specifically for Hepatitis B and C, HIV, CMV (Cytomegalovirus) syphillis and toxicology - a check to see if anything in blood that should not be present.

He said transplant success rates were constantly improving with 85% of heart transplants, 87% of liver transplants and 93% of living kidney grafts surviving the critical first year.

Despite these successes, he said there was still a chronic shortage of donated organs in the UK and urged people to join donor registers.
 
Rabid organ transplant kills Maryland man
http://www.bbc.co.uk/news/world-us-canada-21807466

CDC officials say that both donor and recipient had a type of rabies usually linked to raccoons

A man in the US state of Maryland has died of rabies, which he contracted from an infected kidney transplant more than a year ago, health officials say.

The early March death has led officials to treat three other patients who received organs from the same donor.

The Centers for Disease Control (CDC) say doctors did not suspect rabies as the cause of death in the donor and did not test for it.

Typically no more than three cases of rabies are diagnosed in the US yearly.

The donor died of raccoon rabies in Florida in 2011 after moving there from North Carolina.

The recipients of the donor's heart, liver and other kidney are receiving anti-rabies vaccines, the CDC said in a news release on Friday. They live in Illinois, Georgia and Florida.

"The organ transplantation occurred more than a year before the recipient developed symptoms and died of rabies," the CDC said, adding such an incubation period is much longer than usual but not unheard of.

Despite this case, the benefits of organ transplantation "generally outweigh the risks", the CDC said in a statement.
 
Here's a recent case illustrating how an organ donor's undetected cancer can re-activate and affect recipients of that donor's organs.

Cancer Spreads from Organ Donor to 4 People in 'Extraordinary' Case
It's well known that organ transplants can pass infectious diseases from donors to recipients in rare cases. But even more rarely, transplants can transmit cancer, as a new case shows.

In what's being described as an "extraordinary case," four people in Europe developed breast cancer after they received organs from the same donor, according to a new report.

Three of the patients died from the cancer, which underscores the "often-fatal consequences of donor-derived breast cancer," the authors wrote in their report, published in the July issue of the American Journal of Transplantation. ...

Undetected cancer

The 53-year-old organ donor died from a stroke in 2007, according to the report, written by researchers in the Netherlands and Germany. She had no known medical conditions that would have precluded organ donation, and multiple tests showed no signs of cancer. Doctors transplanted her kidneys, lungs, liver and heart into the donor recipients. (The heart-transplant patient died of unrelated causes shortly after the transplant.)

But 16 months later, a woman who received the lung transplant became ill and was found to have cancer in the lymph nodes in her chest. An analysis of the cancer cells revealed that they were actually breast cancer cells, and DNA in the cancer cells showed that these cells had come from the organ donor. The lung recipient's cancer spread, and she died about a year after her cancer diagnosis, the report said.

At that time, the three other living patients who'd received the donations were notified. Doctors told them that the lung recipient had died from breast cancer tied to her transplant. These patients underwent tests for cancer, which were initially negative.

But in 2011, the liver-transplant patient was found to have breast cancer cells in her liver. The patient didn't want to undergo another liver transplant, because she was afraid of potential complications. A radiation treatment for the cancer was initially helpful, but the cancer later returned, and that patient died in 2014.

The patient who received the left kidney was also later diagnosed with breast cancer in 2013 — six years after her transplant. The cancer had already spread to many other organs, and the patient passed away two months later.

A 32-year-old man who received the right kidney was also diagnosed with breast cancer cells in his transplanted kidney in 2011. But doctors were able to remove the kidney, and the patient stopped taking drugs to suppress his immune system. He also underwent chemotherapy. The treatment was successful, and the man was still cancer-free 10 years after the transplantation surgery.

Low risk

Passing cancer through an organ transplant is "a very, very uncommon event," said Dr. Lewis Teperman, director of organ transplantation at Northwell Health in New Hyde Park, New York, who was not involved in the case. Indeed, transplant recipients have a chance of between 1 in 10,000 and 5 in 10,000 of this happening, according to the report.

"The organ supply is incredibly safe," Teperman told Live Science. That's because organ donors undergo rigorous screening, including family history for disease, such as cancer, and multiple laboratory tests. In this case, the 53-year-old donor underwent a physical exam as well as an ultrasound of the abdomen and heart, a chest X-ray, and an examination of the airways.

Still, even with these robust procedures in place, "it's impossible to screen everything," and there's a very small chance that a donor will have an undetected disease that could be transmitted, Teperman said.

In the current case, the patient had an undetected breast cancer. The donor may have had "micro metastases" or groups of cancer cells that spread from the original cancer site but are too small to be detected with screening or imaging tests, the report said.

It's also easier for such cancer cells to grow in transplant patients, because the patients take drugs to suppress their immune systems. These drugs are needed so that patients' bodies do not reject the new organ, but any foreign cancer cells "would not be rejected either," Teperman said.

It's possible that a CT scan of the donor in this case may have caught the cancer, but the authors noted that it would be impractical to screen all donors in this way, according to The Independent. Routinely performing such tests could lead to the detection of false positives and the rejection of healthy donors, which would lead to a "decrease of the already scarce donor pool," the authors wrote in the study.

"You would have so many worries that you would never procure any organs," Teperman said.

The report concludes that the low rate of cancer transmission from transplantation "implies that current practices of donor screening for malignancy are effective." If cancer does pass from a donor to a recipient, doctors should consider removing transplants from all other patients who received organs from that donor, the researchers wrote.

SOURCE: https://www.livescience.com/63596-organ-donation-transmitted-breast-cancer.html
 
The first confirmed case of a COVID-19 death resulting from transplantation of an infected donor's organ(s) has been reported in Michigan.
Organ transplant patient dies after receiving Covid-infected lungs

Doctors say a woman in Michigan contracted Covid-19 and died last fall two months after receiving a tainted double-lung transplant from a donor who turned out to harbor the virus that causes the disease — despite showing no signs of illness and initially testing negative.

Officials at the University of Michigan Medical School suggested it may be the first proven case of Covid-19 in the U.S. in which the virus was transmitted via an organ transplant. A surgeon who handled the donor lungs was also infected with the virus and fell ill but later recovered.

The incident appears to be isolated — the only confirmed case among nearly 40,000 transplants in 2020. But it has led to calls for more thorough testing of lung transplant donors ...

The virus was transmitted when lungs from a woman from the Upper Midwest, who died after suffering a severe brain injury in a car accident, were transplanted into a woman with chronic obstructive lung disease at University Hospital in Ann Arbor. The nose and throat samples routinely collected from both organ donors and recipients tested negative for SARS-CoV-2, the virus that causes Covid-19. ...

Three days after the operation, however, the recipient spiked a fever; her blood pressure fell and her breathing became labored. Imaging showed signs of lung infection.

As her condition worsened, the patient developed septic shock and heart function problems. Doctors decided to test for SARS-CoV-2, Kaul said. Samples from her new lungs came back positive. ...

A molecular test of a swab from the donor’s nose and throat, taken 48 hours after her lungs were procured, had been negative for SARS-Cov-2. The donor’s family told doctors she had no history of recent travel or Covid-19 symptoms and no known exposure to anyone with the disease.

But doctors had kept a sample of fluid washed from deep within the donor lungs. When they tested that fluid, it was positive for the virus. Four days after the transplant, the surgeon who handled the donor lungs and performed the surgery tested positive, too. Genetic screening revealed that the transplant recipient and the surgeon had been infected by the donor. ...

The transplant recipient deteriorated rapidly, developing multisystem organ failure. Doctors tried known treatments for Covid-19 ... Eventually, she was placed on the last-resort option of ECMO, or extracorporeal membrane oxygenation, to no avail. Life support was withdrawn, and she died 61 days after the transplant. ...

FULL STORY: https://www.nbcnews.com/health/heal...after-receiving-covid-infected-lungs-n1258388
 
This Delaware man contracted tuberculosis from a tainted bone graft product.
First U.S. Lawsuit Filed Against Aziyo Biologics, Inc. And Medtronic, Inc. On Behalf Of Delaware Patient Infected With Tuberculosis After Receiving Tainted Surgical Bone Graft Product During Spinal Fusion

A retired career corrections officer, who contracted tuberculosis (TB) during a spinal fusion operation, today filed the first lawsuit against Delaware biotechnology company Aziyo, Inc., that recently recalled its TB-tainted FiberCel Viable Bone Matrix (VBM) used to promote bone grafts in nearly two dozen orthopedic surgeries at Christiana Care Hospital, and possibly many more across the United States. The filing in the Delaware Superior Court was jointly announced by plaintiff's attorneys from Saltz Mongeluzzi & Bendesky P.C. and Morris James, LLP. Besides Aziyo, Medtronic, Inc., the regenerative medical product's exclusive distributor, was named as a defendant.

Lawrence R. Cohan, who heads Saltz Mongeluzzi's mass tort and toxic tort practices, and Keith E. Donovan, Managing Partner at Morris James, said the complaint (Richard Williams v. Aziyo, Inc. et al., Filing Delaware Superior Court, New Castle County, C.A. No.: N21C-06-166 EMD) includes claims for unspecified compensatory and punitive damages in seeking justice for plaintiff Richard Williams, 74, of Bear, Delaware, who is being treated with antibiotics for his TB infection resulting from the implantation of a tainted bone graft product while he recovers from what should have been an uncomplicated operation at Christiana Care Hospital. As part of the procedure, his medical team relied on Aziyo's proprietary product developed from allograft bone. Surgeons learned only after his surgery on Aril 13, 2021- and before the June 2nd product recall - that their patient was infected with TB. It is a communicable disease that can be fatal. ...
FULL STORY: https://www.prnewswire.com/news-rel...t-product-during-spinal-fusion-301314230.html
 
This new Live Science article provides more context and details about the TB-infected bone repair product mentioned above. There are believed to be 113 recipients of the tainted material.
Large TB outbreak may be caused by surgical 'bone repair product'

More than 100 people may have been exposed to TB bacteria through this product, called FiberCel.

U.S. officials are investigating an unusual outbreak of tuberculosis (TB) infections in people who had spinal surgery. They suspect the culprit is a potentially tainted bone repair product, according to news reports.

More than 100 people may have been exposed to TB bacteria through this product, called FiberCel, during spinal surgeries that occurred this spring, according to The Washington Post. FiberCel is a putty-like substance made from human bone tissue that's used during various orthopedic and spinal surgeries, the Post reported.

Early this month, the maker of FiberCel, Aziyo Biologics Inc., issued a recall of a single lot of the product after one hospital reported that seven out of 23 patients who received FiberCel developed post-surgical infections, and four of these tested positive for TB, according to the recall notice from the Food and Drug Administration (FDA).

The recalled lot came from a single donor cadaver, and it had been shipped to 20 states, according to a statement from Aziyo Biologics. A total of 113 patients received the recalled product, with most suspected TB cases in Indiana and Delaware, the Post reported. ...

According to the Centers for Disease Control and Prevention (CDC), which is investigating the outbreak along with the FDA, these 113 patients "are likely to have been exposed to MTB" or Mycobacterium tuberculosis, the bacteria that causes TB. The CDC is recommending that all patients who received the recalled product should undergo treatment for TB, which typically involves taking antibiotics for six to nine months. ...
FULL STORY: https://www.livescience.com/tuberculosis-outbreak-bone-repair-product-surgery.html

CDC Notice: https://www.cdc.gov/hai/outbreaks/TB-bone-allograft.html
 
Back
Top